Clinical trial
16-week Flexible vs. 8-week Semaglutide Titration
NCT04447859
Study timeline
Study start (actual)2020-02-23Date precision: day
Registry last updated2020-06-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes type2unresolved
Interventions
SemaglutideDRUG · verified · RxNorm: semaglutide
Sponsors & collaborators
Tel-Aviv Sourasky Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04447859 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.